Protamine neutralizes CSPG-mediated inhibition of oligodendrocyte differentiation

Protamine neutralizes CSPG-mediated inhibition of oligodendrocyte differentiation
Protamine neutralizes CSPG-mediated inhibition of oligodendrocyte differentiation. Credit: NIBB

Remyelination is a critical repair process in demyelinating diseases such as multiple sclerosis (MS). Chondroitin sulfate proteoglycans (CSPGs), a family of large molecules consisting of a core protein and glycosaminoglycans comsposed of chains of alternating sugars, are enriched in glial scars. In MS lesions, CSPGs accumulate as constituents of demyelinating plaques, which inhibit the migration and differentiation of oligodendrocyte precursor cells and remyelination.

The research group of Akihiro Fujikawa and Professor Masaharu Noda of the National Institute for Basic Biology (NIBB) developed a screening method to obtain neutralizing agents for canceling the inhibitory effects of CSPGs on oligodendrocyte differentiation. The group found that the inhibitory activity of a representative extracellular matrix CSPG molecule, aggrecan, was neutralized by a polycationic peptide, , that is clinically used to stop the anticoagulant effect of heparin.

They also found that protamine inhibited a receptor-type , PTPRZ. The extracellular region of PTPRZ is highly modified with CS chains, and its phosphatase activity contributes to maintaining immature states of oligodendrocyte precursor cells. Intranasal administration of protamine enhanced myelination in the developing mouse brain, and its intraventricular administration significantly improved the of cuprizone-induced lesions in adult mice.

These results suggest that protamine neutralizes the inhibitory activity of CSPGs, thereby permitting migration of precursor cells into demyelinating sites and promoting their differentiation to mature oligodendrocytes for remyelination.

The results of this research were published in PLOS ONE on Dec 7, 2017.


Explore further

Elucidation of the molecular mechanisms involved in remyelination

More information: Kazuya Kuboyama et al, Protamine neutralizes chondroitin sulfate proteoglycan-mediated inhibition of oligodendrocyte differentiation, PLOS ONE (2017). DOI: 10.1371/journal.pone.0189164
Journal information: PLoS ONE

Provided by National Institutes of Natural Sciences
Citation: Protamine neutralizes CSPG-mediated inhibition of oligodendrocyte differentiation (2017, December 8) retrieved 21 May 2019 from https://medicalxpress.com/news/2017-12-protamine-neutralizes-cspg-mediated-inhibition-oligodendrocyte.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more